Avanos Medical, Inc. (AVNS) reported third-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 36 cents, up 20% year over year. The bottom line met the Zacks Consensus Estimate.GAAP EPS from continuing operations in the quarter under review was 12 cents against the year-ago reported loss of 19 cents per share.RevenuesRevenues totaled $170.4 million, down 0.5% year over year. The metric missed the Zacks Consensus Estimate by 2.7%.Organic sales were up 1.1% year over year.Per manageme ...